No Improvement in Treatment Success with Teriparatide Use for Hip and Pelvic Bone Fractures

How to Cite

OrthoEvidence. No Improvement in Treatment Success with Teriparatide Use for Hip and Pelvic Bone Fractures. ACE Report. 2021;10(1):10. Available from: https://myorthoevidene.com/AceReport/Report/12872

Study Type:Therapy

OE Level Evidence:1

Journal Level of Evidence:1

Effects of Teriparatide on Treatment Outcomes in Osteoporotic Hip and Pelvic Bone Fractures: Meta-analysis and Systematic Review of Randomized Controlled Trials.

Hip Pelvis. 2020 Dec; 32(4): 182–191.

Contributing Authors: NH Moon JH Jang WC Shin SJ Jung

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

A total of 5 randomized controlled trials containing a total of 386 patients were included in this meta-analysis comparing teriparatide (n=181) and placebo (n=205) for the treatment of osteoporotic hip and pelvic bone fractures. The primary outcome of interest was the pooled incidence of treatment failure. Mean follow up of the included studies ranged from 3 to 19.5 months. Results of the meta-ana...